[An Experience of S-1-Induced Rhabdomyolysis and Refractory Enteritis during Postoperative Adjuvant Chemotherapy for Gastric Cancer].

Le résumé fourni par la source

Fluoropyrimidines are one of the key drugs in cancer chemotherapy, but rare adverse events are difficult to diagnose and treat. Here we report a case who developed the relatively rare adverse events of rhabdomyolysis and refractory enteritis during S-1-based chemotherapy for gastric cancer. Because S-1 is frequently used in daily practice of cancer chemotherapy, we should always manage adverse events with detailed knowledge of rare and potentially serious adverse events.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.